Paper Details
- Home
- Paper Details
Original Abstract of the Article :
This study presents data on the use of penfluridol, a once-a-week orally administered, antipsychotic agent, in the treatment of chronic schizophrenic patients. Fifty-nine patients participated in the initial dose titration segment during which doses of penfluridol were adjusted weekly until the pati...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1002/j.1552-4604.1982.tb02667.x
データ提供：米国国立医学図書館（NLM）
Penfluridol vs. Chlorpromazine: A Comparative Study in Chronic Schizophrenia
This study investigates the efficacy of [penfluridol], a once-a-week orally administered [antipsychotic agent], in treating [chronic schizophrenic patients]. The researchers compared [penfluridol] to [chlorpromazine] in a double-blind trial, finding that [penfluridol] was well-tolerated and comparable to [chlorpromazine] in managing [schizophrenic symptoms]. The study highlights the potential of [penfluridol] as a convenient and effective treatment option for [chronic schizophrenia], offering patients a less frequent dosing schedule with comparable efficacy to [daily chlorpromazine] treatment.
Penfluridol: A Promising Option for Chronic Schizophrenia Treatment
This study provides evidence supporting the efficacy of [penfluridol] in managing [chronic schizophrenic patients]. The findings suggest that [penfluridol] is a well-tolerated and effective treatment option, offering a less frequent dosing schedule compared to [daily chlorpromazine] treatment, which may be more convenient for patients. This research underscores the importance of exploring alternative treatment strategies for [chronic schizophrenia], potentially improving patient adherence and outcomes.
Navigating the Landscape of Antipsychotic Treatment
This study highlights the importance of exploring diverse treatment options for [chronic schizophrenia], recognizing the unique needs of individual patients. The findings suggest that [penfluridol] could be a viable alternative to [daily chlorpromazine] treatment, offering patients a less frequent dosing schedule with comparable efficacy. This research underscores the need for a personalized approach to [antipsychotic] treatment, ensuring that patients receive the most effective and well-tolerated care.
Dr. Camel's Conclusion
This study demonstrates the efficacy and tolerability of [penfluridol] in treating [chronic schizophrenic patients]. The findings suggest that [penfluridol] offers a convenient and effective alternative to [daily chlorpromazine] treatment, potentially improving patient adherence and outcomes.
Date :
- Date Completed 1982-10-12
- Date Revised 2019-08-25
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.